Terlipressin Diacetate Salt

• CAT Number: C000383
• CAS Number: 1884420-36-3
• Molecular Formula: C₅₆H₈₂N₁₆O₁₉S₂
• Molecular Weight: 1347.48
• Purity: ≥95%
• Synonyms: 1-Triglycyl-8-lysine Vasopressin Diacetate Salt; 130: PN: WO2010033207 SEQID: 171 claimed protein Diacetate Salt; Glycylpressin Diacetate Salt; Glypressin Diacetate Salt; Nα-Gly-Gly-Gly-8-Lys-vasopressin Diacetate Salt; Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin Diacetate Salt; Nα-Glycyl-glycyl-glycyl-lysine-vasopressin Diacetate Salt; Nα-Glycylglycylglycyl-vasopressin Diacetate Salt; Remestyp Diacetate Salt; Triglycyl-8-lysine-vasopressin Diacetate Salt; [N-α-Triglycyl-8-lysine]-vasopressin Diacetate Salt
• Target: Vasopressin Receptor
• Solubility: DMSO (Slightly), Methanol (Slightly)
• Appearance: White Solid
• Storage: 4°C

Terlipressin Diacetate Salt (CAT: C000383) is a pharmaceutical compound and an analogue of vasopressin. It serves as a vasoactive drug with important clinical applications. Terlipressin is employed in the management of hypotension, particularly in cases where norepinephrine is ineffective, such as in norepinephrine-resistant septic shock and hepatorenal syndrome. Additionally, it plays a crucial role in the treatment of acute variceal bleeding.

Reference

Uriz, J. et al.: J. Heptol., 33, 43 (2000); O’Brien, A. et al.: Lancet, 359, 1209 (2002); Burroughs, A.K. et al.: Digestion, 59, 26 (1998); Villanueva, C. et al.: Am. J. Gastroenterol., 100, 624 (2005);